Integrated BioPharma, Inc.

Equities

INBP

US45811V1052

Pharmaceuticals

Market Closed - OTC Markets 18:46:54 14/05/2024 BST 5-day change 1st Jan Change
0.22 USD +1.38% Intraday chart for Integrated BioPharma, Inc. +0.82% -10.28%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Integrated BioPharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2023 CI
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI
Integrated BioPharma, Inc. Announces the Death of Edward G. Kay, Executive Chairman and President CI
Integrated BioPharma, Inc. Enters into Fourth Amendment to Revolving Credit, Term Loan and Security Agreement CI
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022 CI
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
Integrated BioPharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Integrated Biopharma, Inc. Announces Change in Directors CI
Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q1 Revenue $15.6M MT
Integrated BioPharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022 CI
Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q4 Revenue $14.6M MT
Integrated BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021 CI
Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q3 Revenue $12.8M MT
Integrated BioPharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2021 CI
Integrated Biopharma, Inc. Reports Earnings Results for the Fourth Quarter Ended June 30, 2021 CI
Integrated Biopharma, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2021 CI
Integrated Biopharma, Inc. Reports Earnings Results for the Second Quarter Ended December 31, 2020 CI
Integrated BioPharma : Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q3 Revenue $15.2M MT
Integrated Biopharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2020 CI
Integrated Biopharma, Inc. Appoints Eric Friedman as Director and to the Audit Committee of the Board of Directors CI
Integrated Biopharma, Inc. Reports Earnings Results for the Full Year Ended June 30, 2020 CI
Chart Integrated BioPharma, Inc.
More charts
Integrated Biopharma Inc. is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements, and herbal products. The Company’s business segments include Contract Manufacturing operated by Manhattan Drug Company, Inc. (MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers; and Other Nutraceutical Businesses, which includes the operations of AgroLabs, Inc. (AgroLabs), The Vitamin Factory (the Vitamin Factory), IHT Health Products, Inc. (IHT), MDC Warehousing and Distribution, Inc., and Chem International, Inc. AgroLabs distributes healthful nutritional products for sale through mass market, grocery and drug and vitamin retailers under the brands: Peaceful Sleep, and Wheatgrass and other products. IHT is a distributor of fine natural botanicals, including multi-minerals produced under a license agreement. Chem is a distributor of raw materials.
More about the company
  1. Stock Market
  2. Equities
  3. INBP Stock
  4. News Integrated BioPharma, Inc.
  5. Earnings Flash (INBP) INTEGRATED BIOPHARMA Reports Q4 Revenue $14.6M